Chemotherapy Complications
Palonosetron is effective in preventing nausea and vomiting
Published in Cancer Weekly, September 16th, 2003
According to a study from the United States, "Nausea and vomiting among the serious complications of chemotherapy and can be associated with medical and psychological complications.
"Palonosetron (Aloxi, MGI Pharma/Helsinn) is a new agent in the class of serotonin type 3 (5-HT3) receptor antagonists that have become a standard of care for the prevention of chemotherapy-induced nausea and vomiting. Palonosetron has a much longer half-life (similar to 40 h) than typical 5-HT3 receptor antagonists and potentially improved efficacy in the prevention of delayed nausea and vomiting associated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-09-16)
More Articles from Cancer Weekly
- Bladder Cancer
Survival rates jump significantly with presurgery chemotherapy - Oncogenes
Research pinpoints gene that increases cancer risk by 26% - Breast Cancer
Elevated DNA damage is significantly associated with breast cancer risk - Cancer Mortality
Progress shown in death rates from four leading cancers - MALT Lymphoma
Gene crucial for antibody-producing cell development is key to blood cell cancer - Transduction
A new adaptor protein reactivates mutant p53 to cause tumor destruction - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
